PA GoodDoctor (01833) shares rose more than 8% intraday. As of press time, the stock was up 6.46% at HK$5.93, with a turnover of HK$61.1855 million.
Recently, PA GoodDoctor released its performance report for the first three quarters of 2026. During the period, the company recorded total revenue of RMB 3.508 billion and net profit of RMB 248 million, representing a year-on-year increase of 35%.
During the period, the company continued to deepen its AI capability building and application implementation, building differentiated advantages through a "human + machine + ecosystem" closed loop, and steadily improving the quality and efficiency of professional medical services.
During the period, the number of AI doctor users continued to grow to nearly 13 million. In serious medical scenarios, the company further upgraded its AI-assisted multidisciplinary team (MDT) consultation platform for complex diseases. As of the end of the reporting period, it had covered four major categories of diseases, with an accuracy rate of approximately 90% for complex disease MDT diagnosis and treatment plans. The continuous expansion of disease coverage reflects the gradual deepening of AI capability application in complex disease diagnosis and treatment.
In proactive health management scenarios, the company launched its digital and intelligent health management service "Ping An Smart Private Coaching" under the "AI + real person" model during the period, building a full-process exercise and health management closed loop around "assessment-training-consolidation," and creating a dual-coach companion mechanism featuring exclusive fitness private coaches and AI intelligent coaches. At the same time, the application boundaries of AI capabilities continue to extend to diverse populations and cross-border scenarios.
Comments